Supplementary Data from Oxidative Phosphorylation Is a Metabolic Vulnerability of Endocrine Therapy–Tolerant Persister Cells in ER+ Breast Cancer
Year: 2025
Type: supplementary-materials
Abstract: Clinical study protocol (version 11October2021)
Source: Figshare
Authors: Steven Tau (16677394), Mary D. Chamberlin (15036341), Huijuan Yang (20877807), Jonathan D. Marotti (16005879), Patricia C. Muskus (20877810), Alyssa M. Roberts (16677397), Melissa M. Carmichael (20877813), Lauren Cressey (20877816), Christo Philip C. Dragnev (20877819), Eugene Demidenko (16005894), Riley A. Hampsch (20877822), Shannon M. Soucy (16005888), Fred W. Kolling (20877825), Kimberley S. Samkoe (20877828), James V. Alvarez (15081033), Arminja N. Kettenbach (20877831), Todd W. Miller (16005897)
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: green
OpenAlex ID: W7165025867
Cites:
Cited by:
Related to: